Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1Anus Neoplasms 1Anal Canal Carcinoma 1

Interventions

Radiotherapy 5Oxaliplatin 5Nivolumab 5Fluorouracil 5Cetuximab 5Leucovorin 4Magnetic Resonance Spectroscopy 3Bevacizumab 3sintilimab 2pembrolizumab 2fludarabine 2encorafenib 2aldesleukin 2Tomography, X-Ray Computed 2Specimen Handling 2Pemetrexed 2Magnetic Resonance Imaging 2Irinotecan 2Gemcitabine 2Folfox protocol 2Electrocardiography 2Drug Therapy 2Dexamethasone 2Cyclophosphamide 2Cisplatin 2Carboplatin 2Capecitabine 2Biopsy 2ulixertinib 1trifluridine tipiracil drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rectal Neoplasms × Sigmoidoscopy × 30 days × Clear all
NCT04751370 2026-05-29

Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
31 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡